Abstract Number: 195 • 2013 ACR/ARHP Annual Meeting
Major Cost Savings Associated With Reduced Biologic Dosing Frequency In Inflammatory Arthritis
Background/Purpose: Biologic agents are highly effective in Inflammatory Arthritis (IA) but are extremely expensive. A sustained reduction in biologic dosing frequency would lead to major…